Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133439) titled 'Retrospective cohort study of ustekinumab in Crohn's disease' on Sept. 28.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

Condition: Crohn's disease

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-01

Target Sample Size: Case series:250;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=344809

Published by HT Digital Content Services with permission from Health Daily Digest....